These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2422182)

  • 1. Regulation of the terminal event in cellular differentiation: biological mechanisms of the loss of proliferative potential.
    Wier ML; Scott RE
    J Cell Biol; 1986 May; 102(5):1955-64. PubMed ID: 2422182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aproliferin--a human plasma protein that induces the irreversible loss of proliferative potential associated with terminal differentiation.
    Wier ML; Scott RE
    Am J Pathol; 1986 Dec; 125(3):546-54. PubMed ID: 3799819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of distinct steps in the adipocyte differentiation pathway in 3T3 T mesenchymal stem cells by dimethyl sulphoxide (DMSO).
    Wang H; Scott RE
    Cell Prolif; 1993 Jan; 26(1):55-66. PubMed ID: 8439589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypeptide changes associated with loss of proliferative potential during the terminal event in differentiation.
    Wier ML; Scott RE
    J Cell Biochem; 1987 Feb; 33(2):137-50. PubMed ID: 2437134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated control of proliferation and differentiation of mesenchymal stem cells.
    Filipak M; Estervig DN; Tzen CY; Minoo P; Hoerl BJ; Maercklein PB; Zschunke MA; Edens M; Scott RE
    Environ Health Perspect; 1989 Mar; 80():117-25. PubMed ID: 2647473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor inhibits the terminal event in mesenchymal stem cell differentiation.
    Filipak M; Sparks RL; Tzen CY; Scott RE
    J Cell Physiol; 1988 Nov; 137(2):367-73. PubMed ID: 3192620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aproliferin: a modulator of proliferative potential.
    Wier ML; Scott RE
    Biofactors; 1988 Jul; 1(2):129-31. PubMed ID: 3076440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation, dedifferentiation, and transdifferentiation of BALB/c 3T3 T mesenchymal stem cells: potential significance in metaplasia and neoplasia.
    Sparks RL; Seibel-Ross EI; Wier ML; Scott RE
    Cancer Res; 1986 Oct; 46(10):5312-9. PubMed ID: 3756880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological mechanisms for the loss of the differentiated phenotype by non-terminally differentiated adipocytes.
    Hoerl BJ; Wier ML; Scott RE
    Exp Cell Res; 1984 Dec; 155(2):422-34. PubMed ID: 6209152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct inhibitory effects of dihydroteleocidin B and the phorbol ester tumor promoters on the adipocyte differentiation of 3T3-L1 cells.
    Shimizu Y; Shimizu N; Fujiki H; Sugimura T
    Cancer Res; 1983 Oct; 43(10):4974-9. PubMed ID: 6192912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3T3 cells in adipocytic conversion.
    O'Shea Alvarez MS
    Arch Invest Med (Mex); 1991; 22(2):235-44. PubMed ID: 1726451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective control of terminal differentiation and its role in carcinogenesis in the 3T3 T proadipocyte stem cell line.
    Wier ML; Scott RE
    Cancer Res; 1985 Jul; 45(7):3339-46. PubMed ID: 4005857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation.
    Scott RE; Hoerl BJ; Wille JJ; Florine DL; Krawisz BR; Yun K
    J Cell Biol; 1982 Aug; 94(2):400-5. PubMed ID: 6809770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three distinct effects of SV40 T-antigen gene transfection on cellular differentiation.
    Estervig DN; Minoo P; Tzen CY; Scott RE
    J Cell Physiol; 1990 Mar; 142(3):552-8. PubMed ID: 2312615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle models for the aberrant coupling of growth arrest and differentiation in hyperplasia, metaplasia, and neoplasia.
    Scott RE; Florine DL
    Am J Pathol; 1982 Jun; 107(3):342-8. PubMed ID: 7081388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological mechanisms of phorbol myristate acetate-induced inhibition of proadipocyte differentiation.
    Yun K; Scott RE
    Cancer Res; 1983 Jan; 43(1):88-96. PubMed ID: 6182994
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonterminally differentiated cells express decreased growth factor responsiveness.
    Hoerl BJ; Scott RE
    J Cell Physiol; 1989 Apr; 139(1):68-75. PubMed ID: 2708458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate.
    Jiang H; Lin J; Young SM; Goldstein NI; Waxman S; Davila V; Chellappan SP; Fisher PB
    Oncogene; 1995 Sep; 11(6):1179-89. PubMed ID: 7566979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for cell cycle phase-specific initiation of a program of HL-60 cell myeloid differentiation mediated by inducer uptake.
    Yen A; Albright KL
    Cancer Res; 1984 Jun; 44(6):2511-5. PubMed ID: 6327017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coupling of growth arrest and differentiation at a distinct state in the G1 phase of the cell cycle: GD.
    Scott RE; Florine DL; Wille JJ; Yun K
    Proc Natl Acad Sci U S A; 1982 Feb; 79(3):845-9. PubMed ID: 6174983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.